Overview TransCode is an RNA oncology company created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. For decades, ribonucleic acid, or RNA, has been a topic of investigation by the scientific community as a potentially attractive therapeutic modality because it can target any gene and it lends itself to rational and straightforward drug design. RNA-based therapeutics are highly selective to their targets, potentially making av...
Q2 FY2026 — expected 2026-09-01
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-15 | 2024-12-31 | 0001558370-25-004843 | EDGAR | 112K words |
| 2024-04-01 | 2023-12-31 | 0001410578-24-000413 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001104659-23-040158 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001104659-22-040778 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001829635-25-000004 | EDGAR | 38K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011571 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007759 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015731 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012264 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008298 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001410578-23-002489 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001410578-23-001892 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001104659-23-060810 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001104659-22-118641 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001104659-22-091201 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001104659-22-060806 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001104659-26-022830 | EDGAR | 6K words |
| 2026-02-23 | 0001104659-26-018362 | EDGAR | — |
| 2026-02-05 | 0001104659-26-010668 | EDGAR | — |
| 2026-01-06 | 0001104659-26-001097 | EDGAR | — |
| 2025-12-22 | 0001104659-25-123500 | EDGAR | — |
| 2025-12-11 | 0001104659-25-120146 | EDGAR | — |
| 2025-10-27 | 0001104659-25-102361 | EDGAR | — |
| 2025-10-14 | 0001104659-25-099029 | EDGAR | — |
| 2025-10-08 | 0001104659-25-097799 | EDGAR | — |
| 2025-10-03 | 0001104659-25-096658 | EDGAR | — |
129 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001829635 |
| Ticker | RNAZ |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.transcodetherapeutics.com |
| Listed | 2021-07-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report